Last updated: April 12, 2025
Sponsor: F. Johannes Plate
Overall Status: Active - Not Recruiting
Phase
4
Condition
Knee Injuries
Osteoarthritis
Treatment
Methylprednisolone 4 milligram Tab
Dexamethasone injection
Clinical Study ID
NCT06489626
STUDY24010173
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients indicated for primary total knee arthroplasty.
Access to computer or smartphone for completion of REDCap surveys
Exclusion
Exclusion Criteria:
- Patients less than 18 years of age, patients unable to consent, known diabeticpatients and those with an HgbA1c >6.5 preoperatively, patients who are on chronicsteroid treatments, patients with chronic pain on opioid management, patients withallergies to steroids, patients with a history of peptic ulcer disease, patientswith a history of heart failure and patients with a history of renal and/or hepaticfailure will be excluded. Those that are immunosuppressed as well as pregnant and/orlactating will also be excluded.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Methylprednisolone 4 milligram Tab
Phase: 4
Study Start date:
August 01, 2025
Estimated Completion Date:
December 01, 2025
Connect with a study center
UPMC East
Monroeville, Pennsylvania 15146
United StatesSite Not Available
UPMC Shadyside Hospital
Pittsburgh, Pennsylvania 15232
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.